Ginsenoside Rg1 treatment protects against cognitive dysfunction via inhibiting PLC–CN–NFAT1 signaling in T2DM mice

BACKGROUND: As a complication of Type II Diabetes Mellitus (T2DM), the etiology, pathogenesis, and treatment of cognitive dysfunction are still undefined. Recent studies demonstrated that Ginsenoside Rg1 (Rg1) has promising neuroprotective properties, but the effect and mechanism in diabetes-associa...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Xianan, Kong, Liangliang, Huang, Lei, Su, Yong, Li, Xuewang, Yang, Liu, Ji, Pengmin, Li, Weiping, Li, Weizu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214300/
https://www.ncbi.nlm.nih.gov/pubmed/37252275
http://dx.doi.org/10.1016/j.jgr.2022.12.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214300/
https://www.ncbi.nlm.nih.gov/pubmed/37252275
http://dx.doi.org/10.1016/j.jgr.2022.12.006

Ejemplares similares